Previous Article | Next Article ![]()
Infection and Immunity, March 2005, p. 1399-1403, Vol. 73, No. 3
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.3.1399-1403.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Institute for Medical Microbiology, Technische Universität München, Munich, Germany1
Received 22 September 2004/ Returned for modification 1 November 2004/ Accepted 8 November 2004
|
|
|---|
|
|
|---|
Many pieces of evidence indicate that apoptosis is used as a defense against microbial pathogens (11, 20). Over the last few years, it has been recognized that cell death plays a role in the interplay between chlamydia and host cells; a balance of apoptosis/cell death-inducing and inhibiting factors determines the outcome of the infection (for a comprehensive recent review, see reference 3).
All chlamydial species investigated have the capacity to inhibit apoptosis in the infected cell (5, 6, 10), suggesting that apoptosis also plays a role in the host cell's response to chlamydial infection.
Cell death by apoptosis occurs when an intracellular signal transduction pathway is activated. In the apoptotic signaling pathway, the release of cytochrome c from the mitochondria is a central step that is required to activate caspases and to cause the morphological changes of apoptosis such as nuclear condensation. Only one situation is known in which apoptosis occurs in the absence of cytochrome c release: the activation of caspase-8 through death receptors (Fas, TNFR, and TRAILR) in some cells (type I cells). In type II cells, on the other hand, death receptor signaling also requires the release of cytochrome c (19).
Mitochondrial release of cytochrome c is regulated by the Bcl-2 family of proteins. Bcl-2-like proteins consist of three groups: the proapoptotic subfamily of Bax, Bak, and Bok (effectors of cytochrome c release); antiapoptotic proteins such as Bcl-2 and Bcl-xL (inhibitors of cytochrome c release); and the proapoptotic BH3-only proteins. The latter group is structurally diverse and has in common only a small domain termed the Bcl-2 homology domain 3 (BH3 domain). This group of proteins is required to initiate cytochrome c release (2). At present, eight confirmed members of BH3-only proteins are known (several more have been suggested). One or several of the BH3-only proteins are activated by a given stimulus. The activation of BH3-only proteins can involve transcriptional induction (this is the case for the proteins Puma, Noxa, and Bim), release from sequestration sites (Bim and Bmf), dephosphorylation (Bad), and proteolytic cleavage (Bid). The molecular details are uncertain, and there are probably differences in the precise action of various BH3-only proteins. However, all of them lead to the activation of Bax/Bak, and this activation requires the conserved BH3 domain (2).
The protection of chlamydia-infected cells against external stimuli is profound. Molecular analysis of this protection has shown that the release of cytochrome c is prevented (5, 7). The inhibition of apoptosis is limited to stimuli that act via this release and does not extend to death receptor-induced apoptosis in type I cells (6). Recent work further shows that the inhibition acts upstream of Bax/Bak activation (8, 22).
Significantly, chlamydial infection causes the proteolytic degradation of the BH3-only proteins Bim, Puma, and Bad through a proteasomal activity (8). In this process, a short region in Bim encompassing the BH3 domain was sufficient for degradation. Since the BH3 domain is the only part that is structurally conserved in all BH3-only proteins, we derived the model that all BH3-only proteins are destroyed by the same mechanism during infection. Here we test this model and provide a broader study of this process. Time course experiments suggest that it is indeed the same mechanism that leads to the degradation of Bim, Puma, and Bad. Analysis of the BH3-only proteins Bid, Noxa, and Bmf shows that degradation also extends to these family members and that the accessibility of the BH3 domain is required for destruction.
|
|
|---|
The mycoplasma-free C. trachomatis strain L2 was obtained from the American Type Culture Collection. Chlamydiae were grown in Hep2 cells and purified as described previously (6, 8). Human cells were infected with C. trachomatis at a multiplicity of infection (MOI) of 3.
Induction of apoptosis. HeLa-fas cells (3 x 105/well in six-well plates seeded the day before) or Jurkat cells (106 cells/well in 12-well plates) were infected with chlamydiae or not and then subjected to anti-CD95 monoclonal antibody (MAb) stimulation (CH11; Upstate Biotechnology) at 100 ng/ml.
For inducible expression, Noxa was cloned by PCR into the vector pCDNA4/TO. When stably transfected into cells that stably express the tetracycline repressor (HeLa T-REx cells), the expression can be induced by removal of the suppressor upon addition of tetracycline. This HeLa cell line was first infected or left uninfected and, at the indicated time points postinfection, the expression of Noxa was induced by the addition of tetracycline. Cells were harvested for Western blot analysis as indicated in the figure legends.
Western blot analysis. Cells were harvested at the indicated time points. In some experiments cells were treated with the proteasome inhibitor MG132 (Calbiochem). For detergent extracts, 5 x 105 cells were lysed by incubation in 50 µl of Triton buffer (1% Triton X-100, 0.05 M PIPES-NaOH, 0.05 M HEPES [pH 7.0], 2 mM MgCl2, 1 mM EDTA, 10 mM dithiothreitol, and protease inhibitors [Roche]) for 30 min on ice. After centrifugation at 2,000 x g at 4°C for 10 min, loading buffer was added and the lysates were run on a 12% polyacrylamide gel. Proteins were transferred to nitrocellulose membranes, and membranes were probed with antibodies specific for Bax and Bak (both from Upstate Biotechnology), Bim (polyclonal antibody from rabbits; Sigma), Puma N terminus (antibody from rabbits; Sigma), Bid and Bad (both from Cell Signaling Technology), Bmf (kindly provided by Andreas Strasser, WEHI, Melbourne, Australia; now available from Alexis Biochemicals as clone 17A9), Noxa (Alexis), Bcl-2 (Pharmingen), Bcl-xL (Cell Signaling Technology), chlamydial HSP60 (Affinity BioReagents), or tubulin (Sigma). Proteins were visualized by using peroxidase-conjugated secondary antibodies and a chemiluminescence detection system (Perkin-Elmer/Life Sciences, Boston, Mass.).
|
|
|---|
![]() View larger version (77K): [in a new window] |
FIG. 1. Time course of disappearance of Bim, Puma, and Bad during chlamydial infection. At the indicated time points postinfection with C. trachomatis Triton X-100 extracts of Hep2 cell samples were prepared and analyzed by Western blotting against the Bcl-2-family proteins Bim, Puma, Bad, Bcl-2, Bcl-xL, Bax, and Bak. Detection of tubulin served as a loading control. The top and bottom panels were obtained by reprobing two membranes that contained samples from the same experiments. Degradation of Bim, Puma, and Bad was observed in at least three experiments.
|
![]() View larger version (46K): [in a new window] |
FIG. 2. Degradation of Bim, Puma, and Bad requires proteasomal activity. Hep2 cells were infected with C. trachomatis for 16 h or left uninfected. Then, the indicated amount of the proteasome inhibitor MG132 was added for 8 h. Cells were extracted, and extracts were analyzed by Western blotting with antibodies against Bim, Puma, and Bad. Chlamydial Hsp60 served as a control for chlamydial infection; tubulin served as a protein loading control.
|
![]() View larger version (64K): [in a new window] |
FIG. 3. Disappearance of the BH3-only protein Bmf in chlamydia-infected cells. MEF were infected with C. trachomatis for 24 h. Cells were harvested, and Western blot analysis was performed with an antibody to Bmf (two isoforms of Bmf are detected). The identity of Bmf was confirmed in blots with lysate from Bmf-deficient mice (not shown). Chlamydial Hsp60 was tested as a control of infection; tubulin was tested as a loading control. The experiment was performed twice with very similar results.
|
![]() View larger version (35K): [in a new window] |
FIG. 4. Chlamydial infection prevents the appearance of Noxa protein. (A) Induction of Noxa by tetracycline in HeLa Tet-Noxa cells. Cells stably carrying a construct where Noxa was placed under a tetracycline-inducible promoter were treated with tetracycline for 24 h or left untreated (Noxa expression becomes detectable after about 2 h of treatment and is maximal at approximately 24 h [not shown]). Noxa was detected by Western blotting; tubulin was used as a loading control. (B) Induction of Noxa in infected cells. HeLa Tet-Noxa cells were infected with C. trachomatis or left uninfected. After 24 h, tetracycline was added for 8 h to some wells. Cells were harvested, and Western blot analysis was performed with a Noxa-specific antibody. As established earlier, treatment with antibiotics during this time frame does not affect the antiapoptotic effect of chlamydia (7).
|
Bid is normally inactive and is activated only upon cleavage by caspase-8 to generate the active truncated form (i.e., tBid), which then activates Bax and thus causes cytochrome c release (14, 15). Since Bid is a BH3-only protein it might be expected that it is degraded upon infection by C. trachomatis, but this was not the case (6). However, structural studies revealed a possible explanation for this finding. In intact Bid, the BH3-domain was found to be hidden in the three-dimensional structure of the protein. Caspase-8-cleavage induced structural changes that caused the exposure of the BH3 domain on the surface of tBid (16).
Since chlamydial infection targets the BH3 domain in Bim (8), this led us to speculate that, unlike intact Bid, tBid would be degraded as it is generated during fas stimulation. As shown in Fig. 5, this is indeed the case. In untreated Jurkat cells (Fig. 5, left), as well as in HeLa-fas cells (Fig. 5, right), only inactive full-length Bid was detectable irrespective of infection with C. trachomatis. After stimulation with anti-fas antibodies for 6 h, active tBid could be detected in both cell types. However, in infected cells there was clearly less tBid present. This was not due to less Bid activation since Bid cleavage has been shown to be unaltered by infection in time course experiments in the same cells (6). Furthermore, when HeLa-fas cells were treated with anti-fas antibody in the presence of the proteasome inhibitor MG132, the disappearance of tBid was prevented (Fig. 5, right). Thus, chlamydial infection leads to the degradation of tBid but not Bid by a proteasomal activity.
![]() View larger version (31K): [in a new window] |
FIG. 5. Chlamydial infection leads to the degradation of activated (truncated) Bid. Jurkat or HeLa-fas cells were infected with C. trachomatis or left uninfected. After 24 h of infection cells were treated with MAb to the fas death receptor. In some experiments, the proteasome inhibitor MG132 (50 µM) was added at the same time, as indicated. After 6 h cells were harvested, and extracts were subjected to Western blotting and probed with an antibody that recognizes both Bid and tBid (although sensitivity for tBid is much lower than for Bid). Both Jurkat cells (left) and HeLa-fas cells (right) are shown. Chlamydial Hsp60 served as a control for chlamydial infection; detection of tubulin served as a loading control.
|
|
|
|---|
Although some molecular details are still unclear, there is now ample evidence that BH3-only proteins are required for the release of cytochrome c during apoptosis (2). Experiments with mice deficient for individual BH3-only proteins support the model that a given apoptotic stimulus requires one (in some cases more than one) BH3-only protein. For instance, apoptosis induced by microtubule perturbation is mediated via Bim, and apoptosis upon cytokine withdrawal in lymphocytes is mediated via Bim and Puma, upon gamma irradiation at least to a major part via Puma, glucose withdrawal possibly via Bad, death receptor signaling (in type II cells) via Bid, and DNA-damage in part via Noxa (1, 4, 12, 21, 24). Although this has not been fully explored, the available evidence suggests that at least the vast majority of apoptotic stimuli depends on BH3-only proteins to induce apoptosis. By degradation of BH3-only proteins, chlamydial infection would therefore impose a very broad protection. In fact, the only death stimulus that has been reported not to be blocked by chlamydial infection is a death receptor signal in type I cells (6). This is not surprising, however, since this stimulus operates in the absence of cytochrome c release and therefore without requirement for BH3-only proteins (19). As reported recently, chlamydial infection fails to protect against experimental expression of BH3-only proteins from a strong promoter (8). This indicates that no other protective mechanism operates in infected cells and that therefore the degradation of BH3-only proteins is the relevant event.
Degradation of BH3-only proteins started approximately 16 h postinfection and was complete approximately 24 h postinfection. This correlates well with the time course of the build-up of protection against apoptosis. Fan et al. (5) reported that protection in cells infected with C. trachomatis L2 at an MOI of 5 started at ca. 14 h postinfection and infection with an MOI of 0.5 caused protection starting at approximately 24 h postinfection. We used an MOI of 3 and observed BH3-only degradation at 16 h, demonstrating a good correlation between BH3-only protein degradation and observed protection. The data suggest that a protection against apoptosis is not required earlier during infection, perhaps because the inclusion is a trigger for apoptosis only at later time points.
Although protection against apoptosis has been reported as a prominent feature of chlamydial infection, it has been suggested that apoptosis is also induced through the activation of Bax at later stages of chlamydial infection (18) and the clearance of chlamydia during vaginal infection of mice was enhanced in mice lacking Bax (17). Bax was furthermore under experimental conditions directly (in the absence of BH3-only proteins) activated by oxidative stress (13). It is therefore possible that chlamydial infection might, despite the absence of BH3-only proteins, cause the activation of Bax toward the end of the replicative cycle.
It is still unclear how chlamydia mediate degradation of BH3-only proteins. The finding that the disappearance could be blocked by inhibitors of the cellular proteasome suggests that a chlamydial factor modifies the proteins and thereby targets them for proteasomal destruction. It will have to be the focus of future work to delineate the molecular events leading to this destruction.
We thank Juliane Vier and Christina Hilpert for expert technical assistance.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»